8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Feb 24, 2026 · 4mo ago · Accession 0001193125-26-067026
Plain English
Standard BioTools Inc. reported its financial results for the three months and fiscal year ended December 31, 2025, and provided a revenue outlook for fiscal year 2026. The company also disclosed details regarding its cash and investments following the closing of the SomaLogic transaction.
Filing details
- Company
- STANDARD BIOTOOLS INC.
- Ticker
- LAB
- CIK
- 1162194
- Form type
- 8-K
- Filing date
- Feb 24, 2026
- Report date
- Feb 24, 2026
- Document
- lab-20260224.htm
- Size
- 1.1 MB